The University of Chicago Header Logo

Connection

Ted Skolarus to SEER Program

Back to Details
This is a "connection" page, showing publications Ted Skolarus has written about SEER Program.
Ted Skolarus
Connection Strength
0.684
SEER Program
  1. Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancer. Cancer. 2014 May 01; 120(9):1409-16.
    View in: PubMed
    Score: 0.114
  2. Use of restaging bladder tumor resection for bladder cancer among Medicare beneficiaries. Urology. 2011 Dec; 78(6):1345-9.
    View in: PubMed
    Score: 0.098
  3. Comparison of the treatment of men with prostate cancer between the US and England: an international population-based study. Prostate Cancer Prostatic Dis. 2023 06; 26(2):287-292.
    View in: PubMed
    Score: 0.050
  4. Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2020 06; 18(3):201-209.e2.
    View in: PubMed
    Score: 0.043
  5. Implications of Cystectomy Travel Distance for Hospital Readmission and Survival. Clin Genitourin Cancer. 2019 12; 17(6):e1171-e1180.
    View in: PubMed
    Score: 0.042
  6. Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer. Urol Oncol. 2019 07; 37(7):462-469.
    View in: PubMed
    Score: 0.041
  7. Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly. Eur Urol. 2018 04; 73(4):491-498.
    View in: PubMed
    Score: 0.037
  8. Sharp Decline In Prostate Cancer Treatment Among Men In The General Population, But Not Among Diagnosed Men. Health Aff (Millwood). 2017 01 01; 36(1):108-115.
    View in: PubMed
    Score: 0.035
  9. Accuracy of Prostate-Specific Antigen Values in Prostate Cancer Registries. J Clin Oncol. 2016 10 10; 34(29):3586-3587.
    View in: PubMed
    Score: 0.034
  10. Health Care Integration and Quality among Men with Prostate Cancer. J Urol. 2017 01; 197(1):55-60.
    View in: PubMed
    Score: 0.034
  11. Technology diffusion and prostate cancer quality of care. Urology. 2014 Nov; 84(5):1066-72.
    View in: PubMed
    Score: 0.030
  12. Use of advanced treatment technologies among men at low risk of dying from prostate cancer. JAMA. 2013 Jun 26; 309(24):2587-95.
    View in: PubMed
    Score: 0.027
  13. Managed care and the diffusion of intensity-modulated radiotherapy for prostate cancer. Urology. 2012 Dec; 80(6):1236-42.
    View in: PubMed
    Score: 0.026
  14. Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse. Health Aff (Millwood). 2012 Apr; 31(4):750-9.
    View in: PubMed
    Score: 0.025
  15. Identifying better practices for early-stage bladder cancer. Med Care. 2011 Dec; 49(12):1112-7.
    View in: PubMed
    Score: 0.025
  16. Delays in diagnosis and bladder cancer mortality. Cancer. 2010 Nov 15; 116(22):5235-42.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.